{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:16:21Z","timestamp":1791854181828,"version":"4.3.4"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-024-00547-5","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:12:28Z","timestamp":1726114348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Premature ovarian insufficiency"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-7753","authenticated-orcid":false,"given":"Philippe","family":"Touraine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Plu-Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Duranteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-5100","authenticated-orcid":false,"given":"Elena J.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"547_CR1","first-page":"604","volume":"67","author":"CB Coulam","year":"1986","unstructured":"Coulam, C. B., Adamson, S. C. & Annegers, J. F. Incidence of premature ovarian failure. Obstet. Gynecol. 67, 604\u2013606 (1986).","journal-title":"Obstet. Gynecol."},{"key":"547_CR2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/humrep\/dew027","volume":"31","author":"ESHRE Guideline Group on POI.","year":"2016","unstructured":"ESHRE Guideline Group on POI. et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum. Reprod. 31, 926\u2013937 (2016). A comprehensive review covering the guidelines for POI diagnosis and management.","journal-title":"Hum. Reprod."},{"key":"547_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bpobgyn.2021.09.011","volume":"81","author":"SM McGlacken-Byrne","year":"2022","unstructured":"McGlacken-Byrne, S. M. & Conway, G. S. Premature ovarian insufficiency. Best. Pract. Res. Clin. Obstet. Gynaecol. 81, 98\u2013110 (2022). A comprehensive review covering different topics around POI.","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"547_CR4","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jc.2011-1038","volume":"96","author":"M Bidet","year":"2011","unstructured":"Bidet, M. et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J. Clin. Endocrinol. Metab. 96, 3864\u20133872 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR5","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.12688\/f1000research.11948.1","volume":"6","author":"S Torrealday","year":"2017","unstructured":"Torrealday, S., Kodaman, P. & Pal, L. Premature ovarian insufficiency \u2013 an update on recent advances in understanding and management. F1000Research 6, 2069 (2017).","journal-title":"F1000Research"},{"key":"547_CR6","doi-asserted-by":"publisher","first-page":"lvad018","DOI":"10.1093\/ejendo\/lvad018","volume":"188","author":"S Cambray","year":"2023","unstructured":"Cambray, S., Dubreuil, S., Tejedor, I., Dulon, J. & Touraine, P. Family building after diagnosis of premature ovarian insufficiency: a cross-sectional survey in 324 women. Eur. J. Endocrinol. 188, lvad018 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"547_CR7","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.beem.2021.101600","volume":"35","author":"R Rahman","year":"2021","unstructured":"Rahman, R. & Panay, N. Diagnosis and management of premature ovarian insufficiency. Best. Pract. Res. Clin. Endocrinol. Metab. 35, 101600 (2021).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"547_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.38663","volume":"5","author":"WA Rocca","year":"2022","unstructured":"Rocca, W. A., Smith, C. Y., Gazzuola Rocca, L., Savica, R. & Mielke, M. M. Association of premenopausal bilateral oophorectomy with parkinsonism and Parkinson disease. JAMA Netw. Open. 5, e2238663 (2022).","journal-title":"JAMA Netw. Open."},{"key":"547_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000314681","volume":"30","author":"TKT Phung","year":"2010","unstructured":"Phung, T. K. T. et al. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement. Geriatr. Cogn. Disord. 30, 43\u201350 (2010).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"547_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tem.2018.03.010","volume":"29","author":"I Huhtaniemi","year":"2018","unstructured":"Huhtaniemi, I. et al. Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency. Trends Endocrinol. Metab. Tem. 29, 400\u2013419 (2018).","journal-title":"Trends Endocrinol. Metab. Tem."},{"key":"547_CR11","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0024","volume":"11","author":"EC Vogt","year":"2022","unstructured":"Vogt, E. C. et al. Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts. Endocr. Connect. 11, e220024 (2022).","journal-title":"Endocr. Connect."},{"key":"547_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1210\/er.2016-1047","volume":"37","author":"EJ Tucker","year":"2016","unstructured":"Tucker, E. J., Grover, S. R., Bachelot, A., Touraine, P. & Sinclair, A. H. Premature ovarian insufficiency: new perspectives on genetic cause and phenotypic spectrum. Endocr. Rev. 37, 609\u2013635 (2016). A comprehensive review covering the causes of POI.","journal-title":"Endocr. Rev."},{"key":"547_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63479","volume":"194","author":"J Quilichini","year":"2023","unstructured":"Quilichini, J. et al. Stratification of the risk of ovarian dysfunction by studying the complexity of intermediate and premutation alleles of the FMR1 gene. Am. J. Med. Genet. A. 194, e63479 (2023).","journal-title":"Am. J. Med. Genet. A."},{"key":"547_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1210\/clinem\/dgab775","volume":"107","author":"B Gorsi","year":"2022","unstructured":"Gorsi, B. et al. Causal and candidate gene variants in a large cohort of women with primary ovarian insufficiency. J. Clin. Endocrinol. Metab. 107, 685\u2013714 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR15","doi-asserted-by":"publisher","first-page":"bvab032","DOI":"10.1210\/jendso\/bvab032","volume":"5","author":"S Eskenazi","year":"2021","unstructured":"Eskenazi, S. et al. Next generation sequencing should be proposed to every woman with \u2018idiopathic\u2019 primary ovarian insufficiency. J. Endocr. Soc. 5, bvab032 (2021).","journal-title":"J. Endocr. Soc."},{"key":"547_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.fertnstert.2021.12.023","volume":"117","author":"A Rouen","year":"2022","unstructured":"Rouen, A. et al. Whole exome sequencing in a cohort of familial premature ovarian insufficiency cases reveals a broad array of pathogenic or likely pathogenic variants in 50% of families. Fertil. Steril. 117, 843\u2013853 (2022).","journal-title":"Fertil. Steril."},{"key":"547_CR17","first-page":"1155","volume":"107","author":"EJ Tucker","year":"2022","unstructured":"Tucker, E. J., Tan, T. Y., Stark, Z. & Sinclair, A. H. Genomic testing in premature ovarian insufficiency: proceed with caution. Biol. Reprod. 107, 1155\u20131158 (2022).","journal-title":"Biol. Reprod."},{"key":"547_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/13697137.2020.1804547","volume":"23","author":"N Panay","year":"2020","unstructured":"Panay, N. et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric 23, 426\u2013446 (2020).","journal-title":"Climacteric"},{"key":"547_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/13697137.2019.1574738","volume":"22","author":"S Golezar","year":"2019","unstructured":"Golezar, S., Ramezani Tehrani, F., Khazaei, S., Ebadi, A. & Keshavarz, Z. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric 22, 403\u2013411 (2019).","journal-title":"Climacteric"},{"key":"547_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13697137.2022.2153033","volume":"26","author":"M Li","year":"2023","unstructured":"Li, M. et al. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis. Climacteric 26, 95\u2013102 (2023).","journal-title":"Climacteric"},{"key":"547_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/GME.0000000000001423","volume":"27","author":"N Andany","year":"2020","unstructured":"Andany, N. et al. Prevalence and correlates of early-onset menopause among women living with HIV in Canada. Menopause 27, 66\u201375 (2020).","journal-title":"Menopause"},{"key":"547_CR22","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1210\/jc.2016-3723","volume":"102","author":"W Chemaitilly","year":"2017","unstructured":"Chemaitilly, W. et al. Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort. J. Clin. Endocrinol. Metab. 102, 2242\u20132250 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12905-018-0665-2","volume":"18","author":"K Lagergren","year":"2018","unstructured":"Lagergren, K., Hammar, M., Nedstrand, E., Bladh, M. & Sydsj\u00f6, G. The prevalence of primary ovarian insufficiency in Sweden; a national register study. BMC Womens Health 18, 175 (2018).","journal-title":"BMC Womens Health"},{"key":"547_CR24","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/humrep\/deac014","volume":"37","author":"H Silv\u00e9n","year":"2022","unstructured":"Silv\u00e9n, H. et al. Incidence and familial risk of premature ovarian insufficiency in the Finnish female population. Hum. Reprod. 37, 1030\u20131036 (2022).","journal-title":"Hum. Reprod."},{"key":"547_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/humrep\/deg005","volume":"18","author":"JL Luborsky","year":"2003","unstructured":"Luborsky, J. L., Meyer, P., Sowers, M. F., Gold, E. B. & Santoro, N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum. Reprod. 18, 199\u2013206 (2003).","journal-title":"Hum. Reprod."},{"key":"547_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.maturitas.2019.03.008","volume":"123","author":"GD Mishra","year":"2019","unstructured":"Mishra, G. D. et al. EMAS position statement: predictors of premature and early natural menopause. Maturitas 123, 82\u201388 (2019).","journal-title":"Maturitas"},{"key":"547_CR27","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/humrep\/del382","volume":"22","author":"RG Gosden","year":"2007","unstructured":"Gosden, R. G. et al. Prevalence of premature ovarian failure in monozygotic and dizygotic twins. Hum. Reprod. 22, 610\u2013615 (2007).","journal-title":"Hum. Reprod."},{"key":"547_CR28","first-page":"679","volume":"32","author":"GD Mishra","year":"2017","unstructured":"Mishra, G. D. et al. Early menarche, nulliparity and the risk for premature and early natural menopause. Hum. Reprod. 32, 679\u2013686 (2017).","journal-title":"Hum. Reprod."},{"key":"547_CR29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/antiox12081601","volume":"12","author":"AN Shelling","year":"2023","unstructured":"Shelling, A. N. & Ahmed Nasef, N. The role of lifestyle and dietary factors in the development of premature ovarian insufficiency. Antioxid. Basel Switz. 12, 1601 (2023).","journal-title":"Antioxid. Basel Switz."},{"key":"547_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/gme.0b013e318224f9ac","volume":"19","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Meta-analysis suggests that smoking is associated with an increased risk of early natural menopause. Menopause 19, 126\u2013132 (2012).","journal-title":"Menopause"},{"key":"547_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01330-y","volume":"17","author":"J Cui","year":"2024","unstructured":"Cui, J. & Wang, Y. Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment. J. Ovarian Res. 17, 8 (2024).","journal-title":"J. Ovarian Res."},{"key":"547_CR32","first-page":"37","volume":"16","author":"P Vabre","year":"2017","unstructured":"Vabre, P. et al. Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ. Health Glob. Access. Sci. Source 16, 37 (2017).","journal-title":"Environ. Health Glob. Access. Sci. Source"},{"key":"547_CR33","first-page":"324","volume":"24","author":"C Monteiro","year":"2020","unstructured":"Monteiro, C. et al. A critical analysis of the impact of endocrine disruptors as a possible etiology of primary ovarian insufficiency. JBRA Assist. Reprod. 24, 324\u2013331 (2020).","journal-title":"JBRA Assist. Reprod."},{"key":"547_CR34","doi-asserted-by":"publisher","first-page":"107871","DOI":"10.1016\/j.maturitas.2023.107871","volume":"179","author":"N Evangelinakis","year":"2024","unstructured":"Evangelinakis, N. et al. The influence of environmental factors on premature ovarian insufficiency and ovarian aging. Maturitas 179, 107871 (2024).","journal-title":"Maturitas"},{"key":"547_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ando.2020.04.004","volume":"81","author":"S Lamothe","year":"2020","unstructured":"Lamothe, S., Bernard, V. & Christin-Maitre, S. Gonad differentiation toward ovary. Ann. Endocrinol. 81, 83\u201388 (2020).","journal-title":"Ann. Endocrinol."},{"key":"547_CR36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/MOP.0000000000000236","volume":"27","author":"CM Gordon","year":"2015","unstructured":"Gordon, C. M., Kanaoka, T. & Nelson, L. M. Update on primary ovarian insufficiency in adolescents. Curr. Opin. Pediatr. 27, 511\u2013519 (2015).","journal-title":"Curr. Opin. Pediatr."},{"key":"547_CR37","doi-asserted-by":"crossref","unstructured":"De Felici, M. in Oogenesis (eds Coticchio, G., Albertini, D. F. & De Santis, L.) 19\u201337 (Springer, 2013).","DOI":"10.1007\/978-0-85729-826-3_2"},{"key":"547_CR38","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1152\/physrev.00032.2022","volume":"103","author":"EE Telfer","year":"2023","unstructured":"Telfer, E. E., Grosbois, J., Odey, Y. L., Rosario, R. & Anderson, R. A. Making a good egg: human oocyte health, aging, and in vitro development. Physiol. Rev. 103, 2623\u20132677 (2023).","journal-title":"Physiol. Rev."},{"key":"547_CR39","doi-asserted-by":"publisher","first-page":"11513","DOI":"10.1073\/pnas.2001124117","volume":"117","author":"JM Stringer","year":"2020","unstructured":"Stringer, J. M., Winship, A., Zerafa, N., Wakefield, M. & Hutt, K. Oocytes can efficiently repair DNA double-strand breaks to restore genetic integrity and protect offspring health. Proc. Natl Acad. Sci. USA 117, 11513\u201311522 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"547_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098174","volume":"9","author":"S Takae","year":"2014","unstructured":"Takae, S. et al. Analysis of late-onset ovarian insufficiency after ovarian surgery: retrospective study with 75 patients of post-surgical ovarian insufficiency. PLoS ONE 9, e98174 (2014).","journal-title":"PLoS ONE"},{"key":"547_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ijrobp.2023.08.013","volume":"119","author":"C Hill-Kayser","year":"2023","unstructured":"Hill-Kayser, C. et al. Effects of radiation therapy on the female reproductive tract in childhood cancer survivors: a PENTEC comprehensive review. Int. J. Radiat. Oncol. Biol. Phys. 119, 588\u2013609 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"547_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0015-0282(16)49942-5","volume":"47","author":"N Siddle","year":"1987","unstructured":"Siddle, N., Sarrel, P. & Whitehead, M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil. Steril. 47, 94\u2013100 (1987).","journal-title":"Fertil. Steril."},{"key":"547_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01117-1","volume":"16","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. Effect of hysterectomy on ovarian function: a systematic review and meta-analysis. J. Ovarian Res. 16, 35 (2023).","journal-title":"J. Ovarian Res."},{"key":"547_CR44","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jmig.2018.10.013","volume":"26","author":"CP Vignarajan","year":"2019","unstructured":"Vignarajan, C. P., Malhotra, N. & Singh, N. Ovarian reserve and assisted reproductive technique outcomes after laparoscopic proximal tubal occlusion or salpingectomy in women with hydrosalpinx undergoing in vitro fertilization: a randomized controlled trial. J. Minim. Invasive Gynecol. 26, 1070\u20131075 (2019).","journal-title":"J. Minim. Invasive Gynecol."},{"key":"547_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268021","volume":"17","author":"C-Y Ho","year":"2022","unstructured":"Ho, C.-Y., Chang, Y.-Y., Lin, Y.-H. & Chen, M.-J. Prior salpingectomy impairs the retrieved oocyte number in in vitro fertilization cycles of women under 35 years old without optimal ovarian reserve. PLoS ONE 17, e0268021 (2022).","journal-title":"PLoS ONE"},{"key":"547_CR46","doi-asserted-by":"publisher","first-page":"53.e1","DOI":"10.1016\/j.ajog.2014.07.027","volume":"212","author":"X Ye","year":"2015","unstructured":"Ye, X., Yang, Y. & Sun, X. A retrospective analysis of the effect of salpingectomy on serum antiM\u00fcllerian hormone level and ovarian reserve. Am. J. Obstet. Gynecol. 212, 53.e1\u201353.E10 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"547_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017901","volume":"98","author":"J Luo","year":"2019","unstructured":"Luo, J. et al. The effect of salpingectomy on the ovarian reserve and ovarian response in ectopic pregnancy: a systematic review and meta-analysis. Medicine 98, e17901 (2019).","journal-title":"Medicine"},{"key":"547_CR48","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/AOG.0000000000003266","volume":"133","author":"AJ Ainsworth","year":"2019","unstructured":"Ainsworth, A. J. et al. Tubal ligation and age at natural menopause. Obstet. Gynecol. 133, 1247\u20131254 (2019).","journal-title":"Obstet. Gynecol."},{"key":"547_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.critrevonc.2013.07.007","volume":"89","author":"F Torino","year":"2014","unstructured":"Torino, F. et al. Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. Crit. Rev. Oncol. Hematol. 89, 27\u201342 (2014).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"547_CR50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","volume":"13","author":"RJ Norman","year":"2002","unstructured":"Norman, R. J., Davies, M. J., Lord, J. & Moran, L. J. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol. Metab. Tem. 13, 251\u2013257 (2002).","journal-title":"Trends Endocrinol. Metab. Tem."},{"key":"547_CR51","first-page":"87","volume":"14","author":"K Kazis","year":"2003","unstructured":"Kazis, K. & Iglesias, E. The female athlete triad. Adolesc. Med. Phila. Pa. 14, 87\u201395 (2003).","journal-title":"Adolesc. Med. Phila. Pa."},{"key":"547_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0015-0282(97)81482-3","volume":"68","author":"PA van Noord","year":"1997","unstructured":"van Noord, P. A., Dubas, J. S., Dorland, M., Boersma, H. & te Velde, E. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil. Steril. 68, 95\u2013102 (1997).","journal-title":"Fertil. Steril."},{"key":"547_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000052889","volume":"51","author":"G Testa","year":"2001","unstructured":"Testa, G. et al. Case-control study on risk factors for premature ovarian failure. Gynecol. Obstet. Invest. 51, 40\u201343 (2001).","journal-title":"Gynecol. Obstet. Invest."},{"key":"547_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116057","volume":"10","author":"NM Grindler","year":"2015","unstructured":"Grindler, N. M. et al. Persistent organic pollutants and early menopause in U.S. women. PLoS ONE 10, e0116057 (2015).","journal-title":"PLoS ONE"},{"key":"547_CR55","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/humupd\/dmi024","volume":"11","author":"HS Kok","year":"2005","unstructured":"Kok, H. S., van Asselt, K. M., van der Schouw, Y. T., Peeters, P. H. M. & Wijmenga, C. Genetic studies to identify genes underlying menopausal age. Hum. Reprod. Update 11, 483\u2013493 (2005).","journal-title":"Hum. Reprod. Update"},{"key":"547_CR56","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/humrep\/deab025","volume":"36","author":"Y-T Hsieh","year":"2021","unstructured":"Hsieh, Y.-T. & Ho, J. Y. P. Thyroid autoimmunity is associated with higher risk of premature ovarian insufficiency-a nationwide Health Insurance Research Database study. Hum. Reprod. 36, 1621\u20131629 (2021).","journal-title":"Hum. Reprod."},{"key":"547_CR57","doi-asserted-by":"publisher","first-page":"E1255","DOI":"10.1210\/jc.2011-0414","volume":"96","author":"G Reato","year":"2011","unstructured":"Reato, G. et al. Premature ovarian failure in patients with autoimmune Addison\u2019s disease: clinical, genetic, and immunological evaluation. J. Clin. Endocrinol. Metab. 96, E1255\u2013E1261 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR58","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.fertnstert.2005.04.060","volume":"84","author":"VK Bakalov","year":"2005","unstructured":"Bakalov, V. K. et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil. Steril. 84, 958\u2013965 (2005).","journal-title":"Fertil. Steril."},{"key":"547_CR59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/GCO.0b013e32833b6c70","volume":"22","author":"A La Marca","year":"2010","unstructured":"La Marca, A. et al. Primary ovarian insufficiency: autoimmune causes. Curr. Opin. Obstet. Gynecol. 22, 277\u2013282 (2010). A comprehensive review discussing autoimmune POI.","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"547_CR60","doi-asserted-by":"publisher","first-page":"e2656","DOI":"10.1210\/clinem\/dgab140","volume":"106","author":"EC Vogt","year":"2021","unstructured":"Vogt, E. C. et al. Primary ovarian insufficiency in women with Addison\u2019s disease. J. Clin. Endocrinol. Metab. 106, e2656\u2013e2663 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR61","first-page":"450","volume":"38","author":"F Ceccarelli","year":"2020","unstructured":"Ceccarelli, F. et al. Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study. Clin. Exp. Rheumatol. 38, 450\u2013454 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"547_CR62","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.3390\/ijms22052594","volume":"22","author":"A Szeliga","year":"2021","unstructured":"Szeliga, A. et al. Autoimmune diseases in patients with premature ovarian insufficiency \u2013 our current state of knowledge. Int. J. Mol. Sci. 22, 2594 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"547_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43032-023-01299-5","volume":"31","author":"E Levit","year":"2024","unstructured":"Levit, E., Singh, B., Nylander, E. & Segars, J. H. A systematic review of autoimmune oophoritis therapies. Reprod. Sci. 31, 1\u201316 (2024).","journal-title":"Reprod. Sci."},{"key":"547_CR64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0015-0282(16)58095-9","volume":"65","author":"GS Conway","year":"1996","unstructured":"Conway, G. S., Kaltsas, G., Patel, A., Davies, M. C. & Jacobs, H. S. Characterization of idiopathic premature ovarian failure. Fertil. Steril. 65, 337\u2013341 (1996).","journal-title":"Fertil. Steril."},{"key":"547_CR65","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/humrep\/13.7.1796","volume":"13","author":"W Vegetti","year":"1998","unstructured":"Vegetti, W. et al. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum. Reprod. 13, 1796\u20131800 (1998).","journal-title":"Hum. Reprod."},{"key":"547_CR66","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/humrep\/14.10.2455","volume":"14","author":"YM van Kasteren","year":"1999","unstructured":"van Kasteren, Y. M. et al. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum. Reprod. 14, 2455\u20132459 (1999).","journal-title":"Hum. Reprod."},{"key":"547_CR67","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/gme.0b013e3181cf8521","volume":"17","author":"F Janse","year":"2010","unstructured":"Janse, F. et al. Similar phenotype characteristics comparing familial and sporadic premature ovarian failure. Menopause 17, 758\u2013765 (2010).","journal-title":"Menopause"},{"key":"547_CR68","doi-asserted-by":"publisher","first-page":"626924","DOI":"10.3389\/fendo.2021.626924","volume":"12","author":"B Ishizuka","year":"2021","unstructured":"Ishizuka, B. Current understanding of the etiology, symptomatology, and treatment options in premature ovarian insufficiency (POI). Front. Endocrinol. 12, 626924 (2021).","journal-title":"Front. Endocrinol."},{"key":"547_CR69","doi-asserted-by":"crossref","unstructured":"Tucker, E. J., Jaillard, S. & Sinclair, A. H. in Human Reproductive and Prenatal Genetics (eds Leung, P. C. K. & Qiao, J.) 439\u2013461 (Elsevier, 2023).","DOI":"10.1016\/B978-0-323-91380-5.00027-7"},{"key":"547_CR70","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-021-03779-7","volume":"596","author":"KS Ruth","year":"2021","unstructured":"Ruth, K. S. et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature 596, 393\u2013397 (2021).","journal-title":"Nature"},{"key":"547_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/GIM.0b013e3181fa9fad","volume":"13","author":"FM Hantash","year":"2011","unstructured":"Hantash, F. M. et al. FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor\/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet. Med. 13, 39\u201345 (2011).","journal-title":"Genet. Med."},{"key":"547_CR72","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/01.GIM.0000159898.90221.D3","volume":"7","author":"A Cronister","year":"2005","unstructured":"Cronister, A., DiMaio, M., Mahoney, M. J., Donnenfeld, A. E. & Hallam, S. Fragile X syndrome carrier screening in the prenatal genetic counseling setting. Genet. Med. 7, 246\u2013250 (2005).","journal-title":"Genet. Med."},{"key":"547_CR73","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.braindev.2008.12.015","volume":"32","author":"S Otsuka","year":"2010","unstructured":"Otsuka, S. et al. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev. 32, 110\u2013114 (2010).","journal-title":"Brain Dev."},{"key":"547_CR74","first-page":"204","volume":"66","author":"K-F Huang","year":"2003","unstructured":"Huang, K.-F. et al. Original article pilot screening for fragile X carrier in pregnant women of southern Taiwan. J. Chin. Med. Assoc. 66, 204\u2013209 (2003).","journal-title":"J. Chin. Med. Assoc."},{"key":"547_CR75","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/humrep\/deh635","volume":"20","author":"AK Sullivan","year":"2005","unstructured":"Sullivan, A. K. et al. Association of FMR1 repeat size with ovarian dysfunction. Hum. Reprod. 20, 402\u2013412 (2005).","journal-title":"Hum. Reprod."},{"key":"547_CR76","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","volume":"87","author":"MD Wittenberger","year":"2007","unstructured":"Wittenberger, M. D. et al. The FMR1 premutation and reproduction. Fertil. Steril. 87, 456\u2013465 (2007).","journal-title":"Fertil. Steril."},{"key":"547_CR77","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200468RR","volume":"36","author":"R Rosario","year":"2022","unstructured":"Rosario, R. et al. Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency. FASEB J. 36, e22612 (2022).","journal-title":"FASEB J."},{"key":"547_CR78","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41591-022-02194-3","volume":"29","author":"H Ke","year":"2023","unstructured":"Ke, H. et al. Landscape of pathogenic mutations in premature ovarian insufficiency. Nat. Med. 29, 483\u2013492 (2023). This study performed whole-exome sequencing of a large POI cohort and proposed pathogenic variants.","journal-title":"Nat. Med."},{"key":"547_CR79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ando.2010.02.013","volume":"71","author":"A Bashamboo","year":"2010","unstructured":"Bashamboo, A. & McElreavey, K. NR5A1\/SF-1 and development and function of the ovary. Ann. Endocrinol. 71, 177\u2013182 (2010).","journal-title":"Ann. Endocrinol."},{"key":"547_CR80","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/bdrc.21145","volume":"108","author":"S Domenice","year":"2016","unstructured":"Domenice, S. et al. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals. Birth Defects Res. Part. C. Embryo Today 108, 309\u2013320 (2016).","journal-title":"Birth Defects Res. Part. C. Embryo Today"},{"key":"547_CR81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.maturitas.2019.10.011","volume":"131","author":"S Jaillard","year":"2020","unstructured":"Jaillard, S. et al. Analysis of NR5A1 in 142 patients with premature ovarian insufficiency, diminished ovarian reserve, or unexplained infertility. Maturitas 131, 78\u201386 (2020).","journal-title":"Maturitas"},{"key":"547_CR82","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000519836","volume":"16","author":"EJ Tucker","year":"2022","unstructured":"Tucker, E. J. The genetics and biology of FOXL2. Sex. Dev. 16, 184\u2013193 (2022).","journal-title":"Sex. Dev."},{"key":"547_CR83","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/bies.200900193","volume":"32","author":"RA Veitia","year":"2010","unstructured":"Veitia, R. A. FOXL2 versus SOX9: a lifelong \u2018battle of the sexes\u2019. Bioessays 32, 375\u2013380 (2010).","journal-title":"Bioessays"},{"key":"547_CR84","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/REP-13-0181","volume":"146","author":"JB Kerr","year":"2013","unstructured":"Kerr, J. B., Myers, M. & Anderson, R. A. The dynamics of the primordial follicle reserve. Reproduction. 146, R205\u2013R215 (2013).","journal-title":"Reproduction."},{"key":"547_CR85","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.fertnstert.2006.11.191","volume":"88","author":"A Forabosco","year":"2007","unstructured":"Forabosco, A. & Sforza, C. Establishment of ovarian reserve: a quantitative morphometric study of the developing human ovary. Fertil. Steril. 88, 675\u2013683 (2007).","journal-title":"Fertil. Steril."},{"key":"547_CR86","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cge.13156","volume":"93","author":"MM Fran\u00e7a","year":"2018","unstructured":"Fran\u00e7a, M. M. et al. Identification of the first homozygous 1-bp deletion in GDF9 gene leading to primary ovarian insufficiency by using targeted massively parallel sequencing. Clin. Genet. 93, 408\u2013411 (2018).","journal-title":"Clin. Genet."},{"key":"547_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.maturitas.2020.06.004","volume":"141","author":"S Jaillard","year":"2020","unstructured":"Jaillard, S. et al. New insights into the genetic basis of premature ovarian insufficiency: novel causative variants and candidate genes revealed by genomic sequencing. Maturitas 141, 9\u201319 (2020).","journal-title":"Maturitas"},{"key":"547_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1082","volume":"8","author":"S Khor","year":"2020","unstructured":"Khor, S., Lyu, Q., Kuang, Y. & Lu, X. Novel FSHR variants causing female resistant ovary syndrome. Mol. Genet. Genom. Med. 8, e1082 (2020).","journal-title":"Mol. Genet. Genom. Med."},{"key":"547_CR89","doi-asserted-by":"publisher","first-page":"1013894","DOI":"10.3389\/fendo.2022.1013894","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Identification and characterization of novel compound heterozygous variants in FSHR causing primary ovarian insufficiency with resistant ovary syndrome. Front. Endocrinol. 13, 1013894 (2022).","journal-title":"Front. Endocrinol."},{"key":"547_CR90","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203208119","volume":"119","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Transcription-replication conflicts in primordial germ cells necessitate the Fanconi anemia pathway to safeguard genome stability. Proc. Natl Acad. Sci. USA 119, e2203208119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"547_CR91","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/biolre\/ioad110","volume":"109","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Research progress of the Fanconi anemia pathway and premature ovarian insufficiency. Biol. Reprod. 109, 570\u2013585 (2023).","journal-title":"Biol. Reprod."},{"key":"547_CR92","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.30490","volume":"6","author":"B Fouquet","year":"2017","unstructured":"Fouquet, B. et al. A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency. eLife 6, e30490 (2017).","journal-title":"eLife"},{"key":"547_CR93","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41431-021-00977-9","volume":"30","author":"EJ Tucker","year":"2022","unstructured":"Tucker, E. J. et al. Meiotic genes in premature ovarian insufficiency: variants in HROB and REC8 as likely genetic causes. Eur. J. Hum. Genet. 30, 219\u2013228 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"547_CR94","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa1309635","volume":"370","author":"S Caburet","year":"2014","unstructured":"Caburet, S. et al. Mutant cohesin in premature ovarian failure. N. Engl. J. Med. 370, 943\u2013949 (2014).","journal-title":"N. Engl. J. Med."},{"key":"547_CR95","doi-asserted-by":"publisher","first-page":"E2129","DOI":"10.1210\/jc.2014-1268","volume":"99","author":"L de Vries","year":"2014","unstructured":"de Vries, L. et al. Exome sequencing reveals SYCE1 mutation associated with autosomal recessive primary ovarian insufficiency. J. Clin. Endocrinol. Metab. 99, E2129\u2013E2132 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR96","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jmedgenet-2019-106789","volume":"58","author":"W-B He","year":"2021","unstructured":"He, W.-B. et al. Homozygous variants in SYCP2L cause premature ovarian insufficiency. J. Med. Genet. 58, 168\u2013172 (2021).","journal-title":"J. Med. Genet."},{"key":"547_CR97","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/molehr\/gaaa050","volume":"26","author":"S Jaillard","year":"2020","unstructured":"Jaillard, S. et al. STAG3 homozygous missense variant causes primary ovarian insufficiency and male non-obstructive azoospermia. Mol. Hum. Reprod. 26, 665\u2013677 (2020).","journal-title":"Mol. Hum. Reprod."},{"key":"547_CR98","first-page":"1470","volume":"79","author":"LM Nelson","year":"1994","unstructured":"Nelson, L. M. et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J. Clin. Endocrinol. Metab. 79, 1470\u20131475 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR99","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1172\/JCI83553","volume":"125","author":"A Weinberg-Shukron","year":"2015","unstructured":"Weinberg-Shukron, A. et al. A mutation in the nucleoporin-107 gene causes XX gonadal dysgenesis. J. Clin. Invest. 125, 4295\u20134304 (2015).","journal-title":"J. Clin. Invest."},{"key":"547_CR100","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/505406","volume":"79","author":"A Lacombe","year":"2006","unstructured":"Lacombe, A. et al. Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Am. J. Hum. Genet. 79, 113\u2013119 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"547_CR101","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1172\/JCI78473","volume":"125","author":"S AlAsiri","year":"2015","unstructured":"AlAsiri, S. et al. Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability. J. Clin. Invest. 125, 258\u2013262 (2015).","journal-title":"J. Clin. Invest."},{"key":"547_CR102","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajhg.2014.11.002","volume":"95","author":"MA Wood-Trageser","year":"2014","unstructured":"Wood-Trageser, M. A. et al. MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability. Am. J. Hum. Genet. 95, 754\u2013762 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"547_CR103","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1056\/NEJMc1310150","volume":"370","author":"J Wang","year":"2014","unstructured":"Wang, J., Zhang, W., Jiang, H., Wu, B.-L. & Primary Ovarian Insufficiency Collaboration. Mutations in HFM1 in recessive primary ovarian insufficiency. N. Engl. J. Med. 370, 972\u2013974 (2014).","journal-title":"N. Engl. J. Med."},{"key":"547_CR104","doi-asserted-by":"publisher","first-page":"101168","DOI":"10.1016\/j.arr.2020.101168","volume":"63","author":"JL Chiang","year":"2020","unstructured":"Chiang, J. L. et al. Mitochondria in ovarian aging and reproductive longevity. Ageing Res. Rev. 63, 101168 (2020).","journal-title":"Ageing Res. Rev."},{"key":"547_CR105","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00439-023-02563-z","volume":"142","author":"S Bakhshalizadeh","year":"2023","unstructured":"Bakhshalizadeh, S. et al. Deficiency of the mitochondrial ribosomal subunit, MRPL50, causes autosomal recessive syndromic premature ovarian insufficiency. Hum. Genet. 142, 879\u2013907 (2023).","journal-title":"Hum. Genet."},{"key":"547_CR106","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3390\/genes13112113","volume":"13","author":"BL Kline","year":"2022","unstructured":"Kline, B. L. et al. Integral role of the mitochondrial ribosome in supporting ovarian function: MRPS7 variants in syndromic premature ovarian insufficiency. Genes 13, 2113 (2022).","journal-title":"Genes"},{"key":"547_CR107","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajhg.2013.03.007","volume":"92","author":"SB Pierce","year":"2013","unstructured":"Pierce, S. B. et al. Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome. Am. J. Hum. Genet. 92, 614\u2013620 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"547_CR108","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1073\/pnas.1103471108","volume":"108","author":"SB Pierce","year":"2011","unstructured":"Pierce, S. B. et al. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc. Natl Acad. Sci. USA 108, 6543\u20136548 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"547_CR109","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00439-020-02176-w","volume":"139","author":"EJ Tucker","year":"2020","unstructured":"Tucker, E. J. et al. Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance\/translation disorders (LARS2, TFAM). Hum. Genet. 139, 1325\u20131343 (2020).","journal-title":"Hum. Genet."},{"key":"547_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0207-4","volume":"9","author":"M-L Monin","year":"2014","unstructured":"Monin, M.-L. et al. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J. Rare Dis. 9, 207 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"547_CR111","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/gim.2017.74","volume":"20","author":"L R\u00e9gal","year":"2018","unstructured":"R\u00e9gal, L. et al. PREPL deficiency: delineation of the phenotype and development of a functional blood assay. Genet. Med. 20, 109\u2013118 (2018).","journal-title":"Genet. Med."},{"key":"547_CR112","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/0883073807308705","volume":"23","author":"J Maletkovic","year":"2008","unstructured":"Maletkovic, J. et al. Genetic and clinical heterogeneity in eIF2B-related disorder. J. Child. Neurol. 23, 205\u2013215 (2008).","journal-title":"J. Child. Neurol."},{"key":"547_CR113","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/hmg\/ddy098","volume":"27","author":"A Chen","year":"2018","unstructured":"Chen, A. et al. Mutations in the mitochondrial ribosomal protein MRPS22 lead to primary ovarian insufficiency. Hum. Mol. Genet. 27, 1913\u20131926 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"547_CR114","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41431-022-01252-1","volume":"31","author":"AS Neyroud","year":"2023","unstructured":"Neyroud, A. S. et al. LARS2 variants can present as premature ovarian insufficiency in the absence of overt hearing loss. Eur. J. Hum. Genet. 31, 453\u2013460 (2023).","journal-title":"Eur. J. Hum. Genet."},{"key":"547_CR115","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1212\/WNL.0000000000007098","volume":"92","author":"MS van der Knaap","year":"2019","unstructured":"van der Knaap, M. S. et al. Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy. Neurology 92, e1225\u2013e1237 (2019).","journal-title":"Neurology"},{"key":"547_CR116","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1210\/clinem\/dgac528","volume":"107","author":"EJ Tucker","year":"2022","unstructured":"Tucker, E. J. et al. Premature ovarian insufficiency in CLPB deficiency: transcriptomic, proteomic and phenotypic insights. J. Clin. Endocrinol. Metab. 107, 3328\u20133340 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR117","doi-asserted-by":"publisher","first-page":"1347286","DOI":"10.3389\/fcell.2024.1347286","volume":"12","author":"J Song","year":"2024","unstructured":"Song, J. et al. Effects of reactive oxygen species and mitochondrial dysfunction on reproductive aging. Front. Cell Dev. Biol. 12, 1347286 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"547_CR118","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1530\/EJE-20-0516","volume":"183","author":"V Saari","year":"2020","unstructured":"Saari, V., Holopainen, E., M\u00e4kitie, O. & Laakso, S. Pubertal development and premature ovarian insufficiency in patients with APECED. Eur. J. Endocrinol. 183, 513\u2013520 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"547_CR119","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature05337","volume":"444","author":"E-K Suh","year":"2006","unstructured":"Suh, E.-K. et al. p63 protects the female germ line during meiotic arrest. Nature 444, 624\u2013628 (2006).","journal-title":"Nature"},{"key":"547_CR120","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/humu.24432","volume":"43","author":"EJ Tucker","year":"2022","unstructured":"Tucker, E. J. et al. Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency. Hum. Mutat. 43, 1443\u20131453 (2022).","journal-title":"Hum. Mutat."},{"key":"547_CR121","first-page":"886","volume":"40","author":"EJ Tucker","year":"2019","unstructured":"Tucker, E. J. et al. TP63-truncating variants cause isolated premature ovarian insufficiency. Hum. Mutat. 40, 886\u2013892 (2019).","journal-title":"Hum. Mutat."},{"key":"547_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030709","volume":"7","author":"S Banerjee","year":"2012","unstructured":"Banerjee, S. et al. Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression. PLoS ONE 7, e30709 (2012).","journal-title":"PLoS ONE"},{"key":"547_CR123","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ng0597-88","volume":"16","author":"G Matthijs","year":"1997","unstructured":"Matthijs, G. et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat. Genet. 16, 88\u201392 (1997).","journal-title":"Nat. Genet."},{"key":"547_CR124","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajhg.2010.07.007","volume":"87","author":"SB Pierce","year":"2010","unstructured":"Pierce, S. B. et al. Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault syndrome. Am. J. Hum. Genet. 87, 282\u2013288 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"547_CR125","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1210\/jc.2019-00248","volume":"104","author":"A Jolly","year":"2019","unstructured":"Jolly, A. et al. Exome sequencing of a primary ovarian insufficiency cohort reveals common molecular etiologies for a spectrum of disease. J. Clin. Endocrinol. Metab. 104, 3049\u20133067 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01351-1","volume":"17","author":"P Long","year":"2024","unstructured":"Long, P. et al. Oligogenic basis of premature ovarian insufficiency: an observational study. J. Ovarian Res. 17, 32 (2024).","journal-title":"J. Ovarian Res."},{"key":"547_CR127","doi-asserted-by":"publisher","first-page":"664645","DOI":"10.3389\/fendo.2021.664645","volume":"12","author":"R Rossetti","year":"2021","unstructured":"Rossetti, R. et al. Targeted next-generation sequencing indicates a frequent oligogenic involvement in primary ovarian insufficiency onset. Front. Endocrinol. 12, 664645 (2021).","journal-title":"Front. Endocrinol."},{"key":"547_CR128","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.2007.03073.x","volume":"68","author":"CK Welt","year":"2008","unstructured":"Welt, C. K. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin. Endocrinol. 68, 499\u2013509 (2008).","journal-title":"Clin. Endocrinol."},{"key":"547_CR129","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ejhg.2014.185","volume":"23","author":"V Biancalana","year":"2015","unstructured":"Biancalana, V., Glaeser, D., McQuaid, S. & Steinbach, P. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur. J. Hum. Genet. 23, 417\u2013425 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"547_CR130","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/cen.13105","volume":"86","author":"A Bachelot","year":"2017","unstructured":"Bachelot, A. et al. Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency. Clin. Endocrinol. 86, 223\u2013228 (2017).","journal-title":"Clin. Endocrinol."},{"key":"547_CR131","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejogrb.2024.02.013","volume":"295","author":"M Jiang","year":"2024","unstructured":"Jiang, M. et al. Bone mineral density in patients with primary ovarian insufficiency: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 295, 219\u2013227 (2024).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"547_CR132","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jpag.2017.04.003","volume":"30","author":"K Chaloutsou","year":"2017","unstructured":"Chaloutsou, K., Aggelidis, P., Pampanos, A., Theochari, E. & Michala, L. Premature ovarian insufficiency: an adolescent series. J. Pediatr. Adolesc. Gynecol. 30, 615\u2013619 (2017).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"547_CR133","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jpag.2018.06.006","volume":"31","author":"L Kanner","year":"2018","unstructured":"Kanner, L. et al. Noncytotoxic-related primary ovarian insufficiency in adolescents: multicenter case series and review. J. Pediatr. Adolesc. Gynecol. 31, 597\u2013604 (2018).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"547_CR134","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1200\/JCO.2015.64.3288","volume":"34","author":"W van Dorp","year":"2016","unstructured":"van Dorp, W. et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. J. Clin. Oncol. 34, 3440\u20133450 (2016).","journal-title":"J. Clin. Oncol."},{"key":"547_CR135","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10545-016-9990-5","volume":"40","author":"L Welling","year":"2017","unstructured":"Welling, L. et al. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J. Inherit. Metab. Dis. 40, 171\u2013176 (2017).","journal-title":"J. Inherit. Metab. Dis."},{"key":"547_CR136","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.fertnstert.2008.04.060","volume":"92","author":"RD Sanders","year":"2009","unstructured":"Sanders, R. D. et al. Biomarkers of ovarian function in girls and women with classic galactosemia. Fertil. Steril. 92, 344\u2013351 (2009).","journal-title":"Fertil. Steril."},{"key":"547_CR137","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.rbmo.2019.04.019","volume":"39","author":"E Fraison","year":"2019","unstructured":"Fraison, E., Crawford, G., Casper, G., Harris, V. & Ledger, W. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod. Biomed. Online 39, 467\u2013476 (2019).","journal-title":"Reprod. Biomed. Online"},{"key":"547_CR138","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1093\/humrep\/dead168","volume":"38","author":"LE Verrilli","year":"2023","unstructured":"Verrilli, L. E., Allen-Brady, K., Johnstone, E. B., Alvord, M. A. & Welt, C. K. Family size for women with primary ovarian insufficiency and their relatives. Hum. Reprod. 38, 1991\u20131997 (2023).","journal-title":"Hum. Reprod."},{"key":"547_CR139","doi-asserted-by":"publisher","first-page":"676262","DOI":"10.3389\/fgene.2021.676262","volume":"12","author":"KC Piedade","year":"2021","unstructured":"Piedade, K. C., Spencer, H., Persani, L. & Nelson, L. M. Optimizing fertility in primary ovarian insufficiency: case report and literature review. Front. Genet. 12, 676262 (2021).","journal-title":"Front. Genet."},{"key":"547_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12556","volume":"22","author":"S Osuka","year":"2023","unstructured":"Osuka, S. et al. Follicle development and its prediction in patients with primary ovarian insufficiency: possible treatments and markers to maximize the ability to conceive with residual follicles. Reprod. Med. Biol. 22, e12556 (2023).","journal-title":"Reprod. Med. Biol."},{"key":"547_CR141","doi-asserted-by":"publisher","first-page":"601752","DOI":"10.3389\/fendo.2021.601752","volume":"12","author":"X Jiao","year":"2021","unstructured":"Jiao, X. et al. Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies. Front. Endocrinol. 12, 601752 (2021).","journal-title":"Front. Endocrinol."},{"key":"547_CR142","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.fertnstert.2023.10.015","volume":"121","author":"KH Oktay","year":"2024","unstructured":"Oktay, K. H. & Marin, L. Comparison of orthotopic and heterotopic autologous ovarian tissue transplantation outcomes. Fertil. Steril. 121, 72\u201379 (2024).","journal-title":"Fertil. Steril."},{"key":"547_CR143","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejogrb.2023.11.004","volume":"292","author":"T Finkelstein","year":"2024","unstructured":"Finkelstein, T., Zhang, Y., Vollenhoven, B., Rolnik, D. L. & Horta, F. Successful pregnancy rates amongst patients undergoing ovarian tissue cryopreservation for non-malignant indications: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 292, 30\u201339 (2024).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"547_CR144","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.3390\/cancers14235873","volume":"14","author":"LB Colmorn","year":"2022","unstructured":"Colmorn, L. B. et al. Reproductive and endocrine outcomes in a cohort of Danish women following auto-transplantation of frozen\/thawed ovarian tissue from a single center. Cancers 14, 5873 (2022).","journal-title":"Cancers"},{"key":"547_CR145","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1093\/humrep\/dey321","volume":"33","author":"A Cobo","year":"2018","unstructured":"Cobo, A., Garc\u00eda-Velasco, J., Domingo, J., Pellicer, A. & Remoh\u00ed, J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum. Reprod. 33, 2222\u20132231 (2018).","journal-title":"Hum. Reprod."},{"key":"547_CR146","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s10815-023-02932-7","volume":"40","author":"S Gayete-Lafuente","year":"2023","unstructured":"Gayete-Lafuente, S., Turan, V. & Oktay, K. H. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency. J. Assist. Reprod. Genet. 40, 2777\u20132785 (2023).","journal-title":"J. Assist. Reprod. Genet."},{"key":"547_CR147","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1258\/mi.2010.010014","volume":"16","author":"K Maclaran","year":"2010","unstructured":"Maclaran, K., Horner, E. & Panay, N. Premature ovarian failure: long-term sequelae. Menopause Int. 16, 38\u201341 (2010).","journal-title":"Menopause Int."},{"key":"547_CR148","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/biomedicines7010002","volume":"7","author":"JJ Chae-Kim","year":"2018","unstructured":"Chae-Kim, J. J. & Gavrilova-Jordan, L. Premature ovarian insufficiency: procreative management and preventive strategies. Biomedicines 7, 2 (2018).","journal-title":"Biomedicines"},{"key":"547_CR149","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s40618-016-0467-z","volume":"39","author":"A Podfigurna-Stopa","year":"2016","unstructured":"Podfigurna-Stopa, A. et al. Premature ovarian insufficiency: the context of long-term effects. J. Endocrinol. Invest. 39, 983\u2013990 (2016).","journal-title":"J. Endocrinol. Invest."},{"key":"547_CR150","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4103\/jhrs.JHRS_115_17","volume":"11","author":"V Yadav","year":"2018","unstructured":"Yadav, V. et al. Comparison of obstetric outcomes of pregnancies after donor-oocyte in vitro fertilization and self-oocyte in vitro fertilization: a retrospective cohort study. J. Hum. Reprod. Sci. 11, 370\u2013375 (2018).","journal-title":"J. Hum. Reprod. Sci."},{"key":"547_CR151","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/13697137.2015.1094784","volume":"19","author":"X-Y Tao","year":"2016","unstructured":"Tao, X.-Y., Zuo, A.-Z., Wang, J.-Q. & Tao, F.-B. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric 19, 27\u201336 (2016). A comprehensive review analysing the effect of POI on mortality.","journal-title":"Climacteric"},{"key":"547_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164638","volume":"11","author":"A Bachelot","year":"2016","unstructured":"Bachelot, A. et al. Poor compliance to hormone therapy and decreased bone mineral density in women with premature ovarian insufficiency. PLoS ONE 11, e0164638 (2016).","journal-title":"PLoS ONE"},{"key":"547_CR153","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/GME.0000000000000658","volume":"23","author":"HS Hipp","year":"2016","unstructured":"Hipp, H. S., Charen, K. H., Spencer, J. B., Allen, E. G. & Sherman, S. L. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). Menopause 23, 993\u2013999 (2016).","journal-title":"Menopause"},{"key":"547_CR154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229576","volume":"15","author":"MN Gunning","year":"2020","unstructured":"Gunning, M. N. et al. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: a case-control study. PLoS ONE 15, e0229576 (2020).","journal-title":"PLoS ONE"},{"key":"547_CR155","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.maturitas.2016.04.013","volume":"89","author":"E Armeni","year":"2016","unstructured":"Armeni, E. et al. Maintaining postreproductive health: a care pathway from the European Menopause and Andropause Society (EMAS). Maturitas 89, 63\u201372 (2016).","journal-title":"Maturitas"},{"key":"547_CR156","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/13697137.2023.2273530","volume":"27","author":"R Tang","year":"2024","unstructured":"Tang, R. et al. Changes in menopausal symptoms comparing oral estradiol versus transdermal estradiol. Climacteric 27, 171\u2013177 (2024).","journal-title":"Climacteric"},{"key":"547_CR157","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/13697137.2020.1866530","volume":"24","author":"SR Davis","year":"2021","unstructured":"Davis, S. R. Androgens in premenopausal women and women with premature ovarian insufficiency. Climacteric 24, 459\u2013465 (2021).","journal-title":"Climacteric"},{"key":"547_CR158","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1210\/jc.2013-4145","volume":"99","author":"VB Popat","year":"2014","unstructured":"Popat, V. B. et al. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J. Clin. Endocrinol. Metab. 99, 3418\u20133426 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR159","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.fertnstert.2017.11.035","volume":"109","author":"JP Christ","year":"2018","unstructured":"Christ, J. P. et al. Estrogen deprivation and cardiovascular disease risk in primary ovarian insufficiency. Fertil. Steril. 109, 594\u2013600.e1 (2018).","journal-title":"Fertil. Steril."},{"key":"547_CR160","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s40618-023-02045-z","volume":"46","author":"M Dhakate","year":"2023","unstructured":"Dhakate, M. et al. Bone mineral density, vertebral fractures and trabecular bone score in primary ovarian insufficiency. J. Endocrinol. Invest. 46, 1865\u20131874 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"547_CR161","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/GME.0000000000001592","volume":"27","author":"LBC Gazarra","year":"2020","unstructured":"Gazarra, L. B. C., Bonacordi, C. L., Yela, D. A. & Benetti-Pinto, C. L. Bone mass in women with premature ovarian insufficiency: a comparative study between hormone therapy and combined oral contraceptives. Menopause 27, 1110\u20131116 (2020).","journal-title":"Menopause"},{"key":"547_CR162","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2265.2010.03868.x","volume":"73","author":"PM Crofton","year":"2010","unstructured":"Crofton, P. M. et al. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin. Endocrinol. 73, 707\u2013714 (2010).","journal-title":"Clin. Endocrinol."},{"key":"547_CR163","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1210\/jc.2015-4063","volume":"101","author":"B Cartwright","year":"2016","unstructured":"Cartwright, B., Robinson, J., Seed, P. T., Fogelman, I. & Rymer, J. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density. J. Clin. Endocrinol. Metab. 101, 3497\u20133505 (2016). A comprehensive article covering the effect of HRT on bone mineral density in patients with POI.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR164","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.rbmo.2022.02.006","volume":"44","author":"CR Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves, C. R., Vasconcellos, A. S., Rodrigues, T. R., Comin, F. V. & Reis, F. M. Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis. Reprod. Biomed. Online 44, 1143\u20131157 (2022). A comprehensive article covering the effect of HRT in patients with POI.","journal-title":"Reprod. Biomed. Online"},{"key":"547_CR165","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","volume":"7","author":"WA Rocca","year":"2006","unstructured":"Rocca, W. A., Grossardt, B. R., de Andrade, M., Malkasian, G. D. & Melton, L. J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 7, 821\u2013828 (2006).","journal-title":"Lancet Oncol."},{"key":"547_CR166","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","volume":"16","author":"CM Rivera","year":"2009","unstructured":"Rivera, C. M. et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 16, 15\u201323 (2009).","journal-title":"Menopause"},{"key":"547_CR167","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.mayocp.2016.08.002","volume":"91","author":"WA Rocca","year":"2016","unstructured":"Rocca, W. A. et al. Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study. Mayo Clin. Proc. 91, 1577\u20131589 (2016).","journal-title":"Mayo Clin. Proc."},{"key":"547_CR168","doi-asserted-by":"publisher","first-page":"1229804","DOI":"10.3389\/fendo.2023.1229804","volume":"14","author":"LM Nelson","year":"2023","unstructured":"Nelson, L. M. The truth about 17-beta estradiol: menopause beyond \u201cold wives\u2019 tales\u201d. Front. Endocrinol. 14, 1229804 (2023).","journal-title":"Front. Endocrinol."},{"key":"547_CR169","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/GME.0b013e31829752e0","volume":"21","author":"M Canonico","year":"2014","unstructured":"Canonico, M. et al. Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women\u2019s Health Initiative Hormone Therapy clinical trials. Menopause 21, 214\u2013220 (2014).","journal-title":"Menopause"},{"key":"547_CR170","doi-asserted-by":"publisher","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"\u00d8 Lidegaard","year":"2011","unstructured":"Lidegaard, \u00d8., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E. & L\u00f8kkegaard, E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 343, d6423 (2011).","journal-title":"BMJ"},{"key":"547_CR171","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e2990","volume":"344","author":"O Lidegaard","year":"2012","unstructured":"Lidegaard, O., Nielsen, L. H., Skovlund, C. W. & Lokkegaard, E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ 344, e2990 (2012).","journal-title":"BMJ"},{"key":"547_CR172","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.beem.2012.11.003","volume":"27","author":"G Plu-Bureau","year":"2013","unstructured":"Plu-Bureau, G., Hugon-Rodin, J., Maitrot-Mantelet, L. & Canonico, M. Hormonal contraceptives and arterial disease: an epidemiological update. Best. Pract. Res. Clin. Endocrinol. Metab. 27, 35\u201345 (2013).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"547_CR173","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","volume":"377","author":"LS M\u00f8rch","year":"2017","unstructured":"M\u00f8rch, L. S. et al. Contemporary hormonal contraception and the risk of breast cancer. N. Engl. J. Med. 377, 2228\u20132239 (2017).","journal-title":"N. Engl. J. Med."},{"key":"547_CR174","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00432-021-03629-z","volume":"147","author":"D Huber","year":"2021","unstructured":"Huber, D., Seitz, S., Kast, K., Emons, G. & Ortmann, O. Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review. J. Cancer Res. Clin. Oncol. 147, 2035\u20132045 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"547_CR175","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ijc.20710","volume":"114","author":"A Fournier","year":"2005","unstructured":"Fournier, A., Berrino, F., Riboli, E., Avenel, V. & Clavel-Chapelon, F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int. J. Cancer 114, 448\u2013454 (2005).","journal-title":"Int. J. Cancer"},{"key":"547_CR176","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.fertnstert.2016.09.046","volume":"106","author":"SD Sullivan","year":"2016","unstructured":"Sullivan, S. D., Sarrel, P. M. & Nelson, L. M. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil. Steril. 106, 1588\u20131599 (2016).","journal-title":"Fertil. Steril."},{"key":"547_CR177","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1210\/jc.2009-2509","volume":"95","author":"RJ Santen","year":"2010","unstructured":"Santen, R. J. et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J. Clin. Endocrinol. Metab. 95, s1\u2013s66 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR178","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000356922","volume":"81","author":"C Ankarberg-Lindgren","year":"2014","unstructured":"Ankarberg-Lindgren, C., Kristr\u00f6m, B. & Norjavaara, E. Physiological estrogen replacement therapy for puberty induction in girls: a clinical observational study. Horm. Res. Paediatr. 81, 239\u2013244 (2014).","journal-title":"Horm. Res. Paediatr."},{"key":"547_CR179","doi-asserted-by":"publisher","first-page":"G9","DOI":"10.1530\/EJE-22-0073","volume":"186","author":"A Nordenstr\u00f6m","year":"2022","unstructured":"Nordenstr\u00f6m, A. et al. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline. Eur. J. Endocrinol. 186, G9\u2013G49 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"547_CR180","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/clinem\/dgac167","volume":"107","author":"MH Viuff","year":"2022","unstructured":"Viuff, M. H. et al. Women with Turner syndrome are both estrogen and androgen deficient: the impact of hormone replacement therapy. J. Clin. Endocrinol. Metab. 107, 1983\u20131993 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR181","first-page":"2817","volume":"37","author":"IR McDonald","year":"2022","unstructured":"McDonald, I. R., Welt, C. K. & Dwyer, A. A. Health-related quality of life in women with primary ovarian insufficiency: a scoping review of the literature and implications for targeted interventions. Hum. Reprod. 37, 2817\u20132830 (2022).","journal-title":"Hum. Reprod."},{"key":"547_CR182","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12905-022-02008-1","volume":"22","author":"S Golezar","year":"2022","unstructured":"Golezar, S. et al. Primary ovarian insufficiency quality of life scale (POIQOLS): development and psychometric properties. BMC Womens Health 22, 481 (2022).","journal-title":"BMC Womens Health"},{"key":"547_CR183","doi-asserted-by":"publisher","first-page":"E278","DOI":"10.1210\/jc.2010-0613","volume":"96","author":"PJ Schmidt","year":"2011","unstructured":"Schmidt, P. J. et al. Depression in women with spontaneous 46,XX primary ovarian insufficiency. J. Clin. Endocrinol. Metab. 96, E278\u2013E287 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"547_CR184","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.fertnstert.2008.12.122","volume":"93","author":"M Davis","year":"2010","unstructured":"Davis, M. et al. The psychosocial transition associated with spontaneous 46,XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health. Fertil. Steril. 93, 2321\u20132329 (2010).","journal-title":"Fertil. Steril."},{"key":"547_CR185","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/13697137.2011.571320","volume":"14","author":"D Singer","year":"2011","unstructured":"Singer, D., Mann, E., Hunter, M. S., Pitkin, J. & Panay, N. The silent grief: psychosocial aspects of premature ovarian failure. Climacteric 14, 428\u2013437 (2011).","journal-title":"Climacteric"},{"key":"547_CR186","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/01674820009075624","volume":"21","author":"KL Liao","year":"2000","unstructured":"Liao, K. L., Wood, N. & Conway, G. S. Premature menopause and psychological well-being. J. Psychosom. Obstet. Gynaecol. 21, 167\u2013174 (2000).","journal-title":"J. Psychosom. Obstet. Gynaecol."},{"key":"547_CR187","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12160-015-9750-z","volume":"50","author":"MA Driscoll","year":"2016","unstructured":"Driscoll, M. A. et al. Psychosocial vulnerability, resilience resources, and coping with infertility: a longitudinal model of adjustment to primary ovarian insufficiency. Ann. Behav. Med. 50, 272\u2013284 (2016).","journal-title":"Ann. Behav. Med."},{"key":"547_CR188","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.fertnstert.2008.07.1718","volume":"92","author":"SA Orshan","year":"2009","unstructured":"Orshan, S. A. et al. Women with spontaneous 46,XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women. Fertil. Steril. 92, 688\u2013693 (2009).","journal-title":"Fertil. Steril."},{"key":"547_CR189","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.fertnstert.2007.08.040","volume":"90","author":"SN Kalantaridou","year":"2008","unstructured":"Kalantaridou, S. N. et al. Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency. Fertil. Steril. 90, 1805\u20131811 (2008).","journal-title":"Fertil. Steril."},{"key":"547_CR190","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/gme.0b013e3181f4318d","volume":"18","author":"DMB de Almeida","year":"2011","unstructured":"de Almeida, D. M. B., Benetti-Pinto, C. L. & Makuch, M. Y. Sexual function of women with premature ovarian failure. Menopause 18, 262\u2013266 (2011).","journal-title":"Menopause"},{"key":"547_CR191","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/jsm.12743","volume":"12","author":"CL Benetti-Pinto","year":"2015","unstructured":"Benetti-Pinto, C. L., Soares, P. M., Giraldo, H. P. D. & Yela, D. A. Role of the different sexuality domains on the sexual function of women with premature ovarian failure. J. Sex. Med. 12, 685\u2013689 (2015).","journal-title":"J. Sex. Med."},{"key":"547_CR192","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jsxmed\/qdad006","volume":"20","author":"A Gosset","year":"2023","unstructured":"Gosset, A., Claeys, J. M., Huyghe, E. & Tremollieres, F. Sexual function and quality of life in women with idiopathic premature ovarian insufficiency. J. Sex. Med. 20, 626\u2013632 (2023).","journal-title":"J. Sex. Med."},{"key":"547_CR193","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/GME.0000000000000195","volume":"21","author":"GM Guerrieri","year":"2014","unstructured":"Guerrieri, G. M. et al. Effects of physiologic testosterone therapy on quality of life, self-esteem, and mood in women with primary ovarian insufficiency. Menopause 21, 952\u2013961 (2014).","journal-title":"Menopause"},{"key":"547_CR194","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/13697137.2019.1637079","volume":"22","author":"SR Davis","year":"2019","unstructured":"Davis, S. R. et al. Global consensus position statement on the use of testosterone therapy for women. Climacteric 22, 429\u2013434 (2019).","journal-title":"Climacteric"},{"key":"547_CR195","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.fertnstert.2011.10.031","volume":"97","author":"MP Rosen","year":"2012","unstructured":"Rosen, M. P. et al. A characterization of the relationship of ovarian reserve markers with age. Fertil. Steril. 97, 238\u2013243 (2012).","journal-title":"Fertil. Steril."},{"key":"547_CR196","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-024-00505-1","volume":"10","author":"D Taruscio","year":"2024","unstructured":"Taruscio, D. & Gahl, W. A. Rare diseases: challenges and opportunities for research and public health. Nat. Rev. Dis. Prim. 10, 13 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"547_CR197","doi-asserted-by":"publisher","first-page":"1289592","DOI":"10.3389\/fendo.2024.1289592","volume":"15","author":"LM Nelson","year":"2024","unstructured":"Nelson, L. M. A call for a US National Institute of Women\u2019s Health and Human Development. Front. Endocrinol. 15, 1289592 (2024).","journal-title":"Front. Endocrinol."},{"key":"547_CR198","doi-asserted-by":"publisher","first-page":"111570","DOI":"10.1016\/j.mce.2022.111570","volume":"546","author":"R Sreenivasan","year":"2022","unstructured":"Sreenivasan, R. et al. Whole exome sequencing reveals copy number variants in individuals with disorders of sex development. Mol. Cell. Endocrinol. 546, 111570 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"547_CR199","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0092-8674(95)90275-9","volume":"82","author":"K Aittom\u00e4ki","year":"1995","unstructured":"Aittom\u00e4ki, K. et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82, 959\u2013968 (1995).","journal-title":"Cell"},{"key":"547_CR200","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1172\/JCI3795","volume":"102","author":"I Beau","year":"1998","unstructured":"Beau, I. et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J. Clin. Invest. 102, 1352\u20131359 (1998).","journal-title":"J. Clin. Invest."},{"key":"547_CR201","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1073\/pnas.95.23.13612","volume":"95","author":"A Dierich","year":"1998","unstructured":"Dierich, A. et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl Acad. Sci. USA 95, 13612\u201313617 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"547_CR202","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1210\/mend.13.11.0370","volume":"13","author":"P Touraine","year":"1999","unstructured":"Touraine, P. et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol. Endocrinol. Baltim. Md. 13, 1844\u20131854 (1999).","journal-title":"Mol. Endocrinol. Baltim. Md."},{"key":"547_CR203","doi-asserted-by":"publisher","first-page":"672890","DOI":"10.3389\/fcell.2021.672890","volume":"9","author":"SJ Chon","year":"2021","unstructured":"Chon, S. J., Umair, Z. & Yoon, M.-S. Premature ovarian insufficiency: past, present, and future. Front. Cell Dev. Biol. 9, 672890 (2021). A comprehensive review covering novel approaches for POI diagnosis in the future.","journal-title":"Front. Cell Dev. Biol."},{"key":"547_CR204","doi-asserted-by":"publisher","first-page":"eabm5386","DOI":"10.1126\/sciadv.abm5386","volume":"8","author":"I Stevanovski","year":"2022","unstructured":"Stevanovski, I. et al. Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. Sci. Adv. 8, eabm5386 (2022).","journal-title":"Sci. Adv."},{"key":"547_CR205","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/clinchem\/hvac154","volume":"68","author":"Q Liang","year":"2022","unstructured":"Liang, Q. et al. Comprehensive analysis of fragile X syndrome: full characterization of the FMR1 locus by long-read sequencing. Clin. Chem. 68, 1529\u20131540 (2022).","journal-title":"Clin. Chem."},{"key":"547_CR206","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1210\/endrev\/bnab047","volume":"43","author":"E Tahmasbpour Marzouni","year":"2022","unstructured":"Tahmasbpour Marzouni, E., Stern, C., Henrik Sinclair, A. & Tucker, E. J. Stem cells and organs-on-chips: new promising technologies for human infertility treatment. Endocr. Rev. 43, 878\u2013906 (2022).","journal-title":"Endocr. Rev."},{"key":"547_CR207","doi-asserted-by":"publisher","first-page":"426.e1","DOI":"10.1016\/j.ajog.2023.12.037","volume":"230","author":"J Johnson","year":"2024","unstructured":"Johnson, J., Lawley, S. D., Emerson, J. W. & Oktay, K. Modeling delay of age at natural menopause with planned tissue cryopreservation and autologous transplantation. Am. J. Obstet. Gynecol. 230, 426.e1\u2013426.e8 (2024).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"547_CR208","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0140-6736(11)61781-9","volume":"379","author":"C Poirot","year":"2012","unstructured":"Poirot, C. et al. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 379, 588 (2012).","journal-title":"Lancet"},{"key":"547_CR209","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.maturitas.2020.07.007","volume":"142","author":"EE Kolibianaki","year":"2020","unstructured":"Kolibianaki, E. E., Goulis, D. G. & Kolibianakis, E. M. Ovarian tissue cryopreservation and transplantation to delay menopause: facts and fiction. Maturitas 142, 64\u201367 (2020).","journal-title":"Maturitas"},{"key":"547_CR210","doi-asserted-by":"publisher","first-page":"1273966","DOI":"10.3389\/fendo.2023.1273966","volume":"14","author":"A Iwase","year":"2023","unstructured":"Iwase, A. et al. Anti-M\u00fcllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development. Front. Endocrinol. 14, 1273966 (2023).","journal-title":"Front. Endocrinol."},{"key":"547_CR211","doi-asserted-by":"publisher","first-page":"hoae028","DOI":"10.1093\/hropen\/hoae028","volume":"2024","author":"J Hao","year":"2024","unstructured":"Hao, J. et al. Effects of chemical in vitro activation versus fragmentation on human ovarian tissue and follicle growth in culture. Hum. Reprod. Open. 2024, hoae028 (2024).","journal-title":"Hum. Reprod. Open."},{"key":"547_CR212","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1200\/JOP.18.00710","volume":"15","author":"TA Sussman","year":"2019","unstructured":"Sussman, T. A., Kruse, M. L., Thacker, H. L. & Abraham, J. Managing genitourinary syndrome of menopause in breast cancer survivors receiving endocrine therapy. J. Oncol. Pract. 15, 363\u2013370 (2019).","journal-title":"J. Oncol. Pract."},{"key":"547_CR213","doi-asserted-by":"publisher","first-page":"101561","DOI":"10.1016\/j.beem.2021.101561","volume":"35","author":"E Armeni","year":"2021","unstructured":"Armeni, E., Paschou, S. A., Goulis, D. G. & Lambrinoudaki, I. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. Best. Pract. Res. Clin. Endocrinol. Metab. 35, 101561 (2021).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"547_CR214","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/13697137.2020.1859246","volume":"24","author":"I Lambrinoudaki","year":"2021","unstructured":"Lambrinoudaki, I. et al. Premature ovarian insufficiency: a toolkit for the primary care physician. Climacteric 24, 425\u2013437 (2021).","journal-title":"Climacteric"}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00547-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00547-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00547-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:16:07Z","timestamp":1726114567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00547-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["547"],"URL":"https:\/\/doi.org\/10.1038\/s41572-024-00547-5","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"31 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}